Literature DB >> 3136875

Mechanisms of acute lung injury. What have we learned from experimental animal models?

M R Flick1.   

Abstract

Studies have shown that there are at least two broad categories of acute lung injuries: those that require polymorphonuclear leukocytes, and those that do not. Knowledge from animal experiments is very incomplete, and the relevance of animal models to human disease is unknown. Specific therapy appears to be a distant goal, because there is no single underlying mechanism of lung injury, and because there is no way to precisely identify what injured the lung or to make a clinical diagnosis early enough in lung injury. Many possibilities for therapy are based on interfering with inflammation, and may therefore increase susceptibility to infection. Considerable progress is being made, but there is much left to learn.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3136875

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  4 in total

1.  Extravascular lung water as an indicator of pulmonary dysfunction in acute hemorrhagic pancreatitis.

Authors:  C A Burnweit; J W Horton
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

2.  Adult respiratory distress syndrome after limited resection of adenocarcinoma of the lung.

Authors:  S el Bayadi; D B Ettensohn; J Yashar
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

3.  Physiologic, biochemical, and imaging characterization of acute lung injury in mice.

Authors:  Zhaohui Zhou; James Kozlowski; Daniel P Schuster
Journal:  Am J Respir Crit Care Med       Date:  2005-05-13       Impact factor: 21.405

4.  Resolvins Decrease Oxidative Stress Mediated Macrophage and Epithelial Cell Interaction through Decreased Cytokine Secretion.

Authors:  Ruan Cox; Oluwakemi Phillips; Jutaro Fukumoto; Itsuko Fukumoto; Prasanna Tamarapu Parthasarathy; Maria Mandry; Young Cho; Richard Lockey; Narasaiah Kolliputi
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.